HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Del Labs

This article was originally published in The Rose Sheet

Executive Summary

Third quarter net sales rose 4.7% to $99.7 mil., driven by solid performance of the company's core brands, including Sally Hansen, which maintained its top ranking in the mass market nail care category, Del Labs reports in an Oct. 28 release. Sally Hansen has a 26% market share in the segment the company notes, citing ACNielsen figures. Despite strong sales, overall earnings fell 8.7% to $4.7 mil., impacted by higher advertising and display costs primarily associated with the launch of the brand's new Healing Beauty color range, which bowed early in the year (1"The Rose Sheet" Dec. 2, 2002, p. 3)...

You may also be interested in...



Sally Hansen Color Cosmetics Bring Healing Positioning To Category

Del Labs is making a full-scale push into the color cosmetics category in January with the launch of Sally Hansen Healing Beauty, a makeup line with a "good-for-you" positioning, Exec VP-Marketing William McMenemy said

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011629

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel